- Home
- IFRX vs CPBI Comparison
IFRX vs CPBI Comparison
Compare IFRX & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- CPBI
- Stock Information
- Founded
- IFRX 2007
- CPBI 2023
- Country
- IFRX Germany
- CPBI United States
- Employees
- IFRX N/A
- CPBI N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- CPBI
- Sector
- IFRX Health Care
- CPBI
- Exchange
- IFRX Nasdaq
- CPBI Nasdaq
- Market Cap
- IFRX 65.8M
- CPBI 57.1M
- IPO Year
- IFRX 2017
- CPBI N/A
- Fundamental
- Price
- IFRX $1.69
- CPBI $14.81
- Analyst Decision
- IFRX Strong Buy
- CPBI
- Analyst Count
- IFRX 4
- CPBI 0
- Target Price
- IFRX $8.50
- CPBI N/A
- AVG Volume (30 Days)
- IFRX 262.5K
- CPBI 1.9K
- Earning Date
- IFRX 05-07-2025
- CPBI 01-01-0001
- Dividend Yield
- IFRX N/A
- CPBI N/A
- EPS Growth
- IFRX N/A
- CPBI 29.70
- EPS
- IFRX N/A
- CPBI 1.62
- Revenue
- IFRX $140,242.00
- CPBI $18,546,000.00
- Revenue This Year
- IFRX $61.96
- CPBI N/A
- Revenue Next Year
- IFRX $80.59
- CPBI N/A
- P/E Ratio
- IFRX N/A
- CPBI $9.24
- Revenue Growth
- IFRX 30.90
- CPBI 13.73
- 52 Week Low
- IFRX $0.82
- CPBI $9.96
- 52 Week High
- IFRX $2.82
- CPBI $15.50
- Technical
- Relative Strength Index (RSI)
- IFRX 62.40
- CPBI 51.49
- Support Level
- IFRX $1.53
- CPBI $14.82
- Resistance Level
- IFRX $1.92
- CPBI $14.97
- Average True Range (ATR)
- IFRX 0.19
- CPBI 0.04
- MACD
- IFRX 0.02
- CPBI 0.00
- Stochastic Oscillator
- IFRX 74.59
- CPBI 40.74
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.